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Abstract

Results

Design

IVF outcome comparison among ET, FET and FET/PGT groups

OBJECTIVE: To study the effects of FET and FET post PGT (FET/PGT) on pre-term and very pre-term deliveries in
patients undergoing IVF with elective single embryo transfer (eSET).
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DESIGN: Retrospective cohort Society for Assisted Reproductive Technology (SART) data study.
MATERIALS AND METHODS: A retrospective cohort study was conducted using the publicly available data in the
SART National Summary Report from 2014 to 2017. Cycle inclusion criteria were eSET, fresh embryo transfers (ET),
and frozen embryo transfers (FET) with or without PGT (FET/PGT). Exclusion criteria were use of gestational carriers
and donor eggs. Pregnancy outcomes included live births and gestational age at delivery (term: ≥37 weeks, pre-term:
≥32 to <37 weeks, and very pre-term: <32 weeks). Chi-squared test was used to compare variables between groups. A
P value of < 0.05 was considered statistically significant.
RESULTS: A total of 161,550 eSETs were analyzed for the effect of FET and PGT on IVF outcome and pre-term
deliveries including 43,618 ETs, 58,812 FETs and 59,120 frozen embryo transfers post PGT (FET/PGT). Live birth
rates in patients with FET/PGT were significantly higher than those in ET (52.9% vs 46.4%, P < 0.0001) and FET
(52.9% vs 43.1%, P < 0.0001). Patients with FET had significantly lower live birth rate compared with that of ET
(43.1% vs 46.4%, P < 0.0001). Both FET and FET/PGT significantly increased term deliveries compared with ET
(89.1% and 89.5% vs 88.6%, P < 0.05 and < 0.001). There were no statistical differences among ET, FET and
FET/PGT in terms of pre-term delivery, however, FET/PGT significantly reduced very pre-term deliveries when
compared with ET and FET (1.5% vs 2.0%, P < 0.0001 and 1.5% vs 1.9%, P = 0.0002).
Conclusion: PGT has been integrated into one of the most important roles in IVF treatment. This study using large
cohort SART data demonstrates that PGT significantly improves IVF outcome. Moreover, this study shows that
patients undergoing PGT accompanied with subsequent FET had significantly increased term deliveries. More
important, patients with FET/PGT had significantly lower very preterm deliveries compared with patients with ET and
FET. Higher term deliveries and Lower incidence of very pre-term delivery associated with PGT should be taken into
account when counseling patients seeking infertility treatment.

Objective

Results

To study the effects of FET and FET post PGT (FET/PGT) on pre-term and very
pre-term deliveries in patients undergoing IVF with elective single embryo transfer
(eSET).

Comparison of term births among ET, FET, and FET/PGT groups

Pre-term delivery is associated with significant perinatal morbidity and mortality

•

Multiple risk factors including age, ethnicity, and socioeconomic status.

•

Associated causes including pre-term pre-labor rupture of membranes (PPROM),
maternal or fetal infections such as chorioamnionitis, diabetes, and preeclampsia.

% of total live births

96.0

Background

90.0

•

Patients with FET had significantly lower live birth rate compared with that of
ET (43.1% vs 46.4%, P < 0.0001).

•

Both FET and FET/PGT significantly increased term deliveries compared with
ET (89.1% and 89.5% vs 88.6%, P < 0.05 and < 0.001).

•

No statistical difference in pre-term birth rate between ET, FET and FET/PGT

•

FET/PGT significantly reduced very pre-term deliveries compared to ET and
FET (1.5% vs 2.0%, P < 0.0001 and 1.5% vs 1.9%, P = 0.0002), respectively.

Discussion
Compared to fresh embryo transfer, FET with or without PGT was
associated with increased term births.

•

Patients undergoing PGT with subsequent FET also had significantly lower
rates of very pre-term births compared to the ET and FET groups.

•

Preterm-birth is associated with significant short- and long-term neonatal
morbidity/mortality, as well as significant financial, psychological, and
emotion to the families involved.

•

The synergistic effect of PGT with FET in decreasing very pre-term births
should be taken into account when counseling patients about to undergo
infertility treatment.

•

With decreasing associated costs over time, adoption of PGT with FET as
the standard of care in IVF should be considered.
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Studies of effect of PGT on neonatal outcomes are relatively rare.
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•

Live birth rates in patients with FET/PGT were significantly higher than those
in ET (52.9% vs 46.4%, P < 0.0001) and FET (52.9% vs 43.1%, P < 0.0001).
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IVF is associated with higher prevalence of pre-term birth.
PGT for aneuploidy screening significantly increases implantation and live birth rates,
as well as decreasing miscarriage rates.
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